Ci Private Wealth, LLC Repligen Corp Transaction History

Ci Private Wealth, LLC

$68.1 Billion
Q2 2025

A detailed history of Ci Private Wealth, LLC transactions in Repligen Corp stock. As of the latest transaction made, Ci Private Wealth, LLC holds 3,672 shares of RGEN stock, worth $533,284. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,672

Previous 3,672 -0.0%

Holding current value

$533,284

Previous $456,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	BUY	$108.89 - $145.23 $5,662 - $7,551	52 Added 1.44%	3,672 $456,000
Q1 2025 May 14, 2025	BUY	$127.24 - $174.24 $43,134 - $59,067	339 Added 10.33%	3,620 $460,000
Q4 2024 Feb 10, 2025	SELL	$123.41 - $160.92 $49,981 - $65,172	-405 Reduced 10.99%	3,281 $472,000
Q3 2024 Nov 12, 2024	SELL	$119.79 - $167.35 $265,933 - $371,517	-2,220 Reduced 37.59%	3,686 $548,000
Q2 2024 Aug 13, 2024	SELL	$120.0 - $182.95 $146,520 - $223,381	-1,221 Reduced 17.13%	5,906 $744,000
Q1 2024 May 09, 2024	BUY	$170.78 - $208.42 $19,810 - $24,176	116 Added 1.65%	7,127 $1.31 Million
Q4 2023 Feb 09, 2024	BUY	$114.17 - $185.35 $174,908 - $283,956	1,532 Added 27.96%	7,011 $1.26 Million
Q3 2023 Nov 03, 2023	BUY	$138.78 - $176.51 $404,960 - $515,056	2,918 Added 113.94%	5,479 $871,000
Q2 2023 Aug 10, 2023	SELL	$138.42 - $180.31 $223,271 - $290,840	-1,613 Reduced 38.64%	2,561 $362,000
Q1 2023 May 15, 2023	BUY	$154.26 - $198.1 $136,211 - $174,922	883 Added 26.83%	4,174 $702,000
Q4 2022 Feb 15, 2023	BUY	$162.42 - $220.56 $534,524 - $725,862	3,291 New	3,291 $557,000

Others Institutions Holding RGEN

# of Institutions

504

Shares Held

58.7M

Call Options Held

89.3K

Put Options Held

679K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.06B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ci Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ci Private Wealth, LLC with notifications on news.

Account

Ci Private Wealth, LLC Repligen Corp Transaction History